7,329 XNAS Volume
XNAS 28 Mar, 2025 9:36 AM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 11 Mar 2025 | 2,153 | 195,840 | - | 11.4 | 24,501 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 11 Mar 2025 | 1,343 | 122,330 | - | 11.4 | 15,283 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 1,094 | 197,993 | - | 11.8 | 12,942 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 917 | 123,673 | - | 11.8 | 10,848 | Common Stock |
John G. Cox | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 4,061 | 146,239 | - | 11.8 | 48,042 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 18 Feb 2025 | 2,598 | 199,087 | - | 13.9 | 36,242 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 18 Feb 2025 | 2,488 | 124,590 | - | 14.0 | 34,708 | Common Stock |
Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 27 Jan 2025 | 1,111,111 | 1,958,427 | - | 13.5 | 14,999,999 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 11 Dec 2024 | 1,455 | 127,078 | - | 28.1 | 40,915 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 11 Dec 2024 | 2,334 | 201,685 | - | 28.1 | 65,632 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 06 Dec 2024 | 101,675 | 5,434,982 | - | 29.3 | 2,983,145 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.18 per share. | 06 Dec 2024 | 34,437 | 5,400,545 | - | 29.2 | 1,004,872 | Common Stock |
John G. Cox | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 145,300 | 150,300 | - | 0 | Common Stock | |
John G. Cox | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 232,100 | 232,100 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 32,700 | 128,533 | - | 0 | Common Stock | |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.05 per share. | 04 Dec 2024 | 3,806 | 5,536,657 | - | 29.0 | 110,564 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.39 per share. | 04 Dec 2024 | 135,039 | 5,540,463 | - | 29.4 | 3,968,796 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 39,100 | 176,619 | - | 0 | Common Stock | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 62,400 | 62,400 | - | - | Stock option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 27,400 | 204,019 | - | 0 | Common Stock | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 52,300 | 52,300 | - | - | Stock option (right to buy) | |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.66 per share. | 02 Dec 2024 | 79,973 | 5,706,462 | - | 29.7 | 2,371,999 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 29.05 per share. | 02 Dec 2024 | 29,732 | 5,675,502 | - | 29.1 | 863,715 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 02 Dec 2024 | 1,228 | 5,705,234 | - | 30.4 | 37,294 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 18 Nov 2024 | 2,735 | 95,833 | - | 28.2 | 77,127 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 18 Nov 2024 | 2,856 | 137,519 | - | 28.2 | 80,539 | Common Stock |
Carlo Incerti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.69 per share. | 18 Nov 2024 | 16,500 | 16,500 | - | 8.7 | 143,385 | Common Stock |
Carlo Incerti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 16,500 | 22,693 | - | - | Stock option (right to buy) | |
Carlo Incerti | Director | Sale of securities on an exchange or to another person at price $ 28.73 per share. | 18 Nov 2024 | 16,500 | 0 | - | 28.7 | 474,045 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 583 | 5,697,508 | - | 33.1 | 19,297 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 123 | 1,458,568 | - | 33.1 | 4,071 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 14 Nov 2024 | 72 | 847,316 | - | 33.1 | 2,383 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 14 Nov 2024 | 4 | 15,962 | - | 33 | 132 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 32.82 per share. | 13 Nov 2024 | 8,929 | 5,786,435 | - | 32.8 | 293,050 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.24 per share. | 13 Nov 2024 | 10,803 | 62,301 | - | 35.2 | 380,698 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 18 Oct 2024 | 121 | 73,104 | - | 35.1 | 4,242 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.16 per share. | 18 Oct 2024 | 13,414 | 73,225 | - | 35.2 | 471,636 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.17 per share. | 16 Oct 2024 | 13,013 | 86,639 | - | 35.2 | 457,667 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.35 per share. | 16 Oct 2024 | 23,671 | 99,652 | - | 35.4 | 836,770 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.13 per share. | 03 Oct 2024 | 5,441 | 123,323 | - | 35.1 | 191,142 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.16 per share. | 01 Oct 2024 | 8,423 | 150,282 | - | 35.2 | 296,153 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.38 per share. | 01 Oct 2024 | 21,518 | 128,764 | - | 35.4 | 761,307 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.47 per share. | 27 Sep 2024 | 29,007 | 160,640 | - | 35.5 | 1,028,878 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 27 Sep 2024 | 1,935 | 158,705 | - | 36.0 | 69,699 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Sep 2024 | 32 | 189,647 | - | 35 | 1,120 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.29 per share. | 25 Sep 2024 | 1,260 | 189,679 | - | 35.3 | 44,465 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 25 Sep 2024 | 2,357 | 190,939 | - | 35.1 | 82,636 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 36.45 per share. | 20 Sep 2024 | 78,940 | 234,598 | - | 36.5 | 2,877,363 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 36.33 per share. | 20 Sep 2024 | 4,610 | 193,296 | - | 36.3 | 167,481 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 20 Sep 2024 | 36,221 | 197,906 | - | 35.2 | 1,274,617 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 20 Sep 2024 | 471 | 234,127 | - | 37.0 | 17,432 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,636 | 131,636 | - | 34.4 | 159,525 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,340 | 136,272 | - | 34.4 | 149,339 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 34.55 per share. | 18 Sep 2024 | 1,390 | 98,568 | - | 34.6 | 48,025 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.55 per share. | 18 Sep 2024 | 2,339 | 140,375 | - | 34.5 | 80,812 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 36.41 per share. | 18 Sep 2024 | 50,972 | 313,538 | - | 36.4 | 1,855,891 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.74 per share. | 18 Sep 2024 | 27,767 | 364,510 | - | 35.7 | 992,393 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 18 Sep 2024 | 1,554 | 392,277 | - | 35.0 | 54,437 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.13 per share. | 16 Sep 2024 | 3,272 | 393,831 | - | 35.1 | 114,945 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.04 per share. | 16 Sep 2024 | 1,320 | 397,103 | - | 35.0 | 46,253 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,722 | 140,612 | - | 31.9 | 86,805 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,548 | 143,334 | - | 31.9 | 81,256 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 1,468 | 99,958 | - | 31.9 | 46,815 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,161 | 142,714 | - | 31.9 | 68,914 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 06 Sep 2024 | 6,502 | 117,524 | - | 5.5 | 36,021 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.88 per share. | 06 Sep 2024 | 6,552 | 227,500 | - | 10.9 | 71,286 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 32.14 per share. | 06 Sep 2024 | 124,374 | 103,126 | - | 32.1 | 3,997,380 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 06 Sep 2024 | 1,700 | 101,426 | - | 32.6 | 55,471 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 6,502 | 0 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 3,353 | 0 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 34,833 | 742 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 16,696 | 8,348 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 29,792 | 25,208 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 18,750 | 26,250 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 6,552 | 28,394 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.72 per share. | 06 Sep 2024 | 18,750 | 220,948 | - | 10.7 | 201,000 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.58 per share. | 06 Sep 2024 | 29,792 | 202,198 | - | 8.6 | 255,615 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.12 per share. | 06 Sep 2024 | 16,696 | 172,406 | - | 13.1 | 219,052 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 06 Sep 2024 | 34,833 | 155,710 | - | 19 | 661,827 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 06 Sep 2024 | 3,353 | 120,877 | - | 5.5 | 18,576 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 05 Sep 2024 | 1,577 | 398,423 | - | 35.0 | 55,242 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 30 Aug 2024 | 6,204 | 400,000 | - | 46.0 | 285,446 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.49 per share. | 30 Aug 2024 | 25,096 | 406,204 | - | 45.5 | 1,141,617 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.41 per share. | 28 Aug 2024 | 16,386 | 549,175 | - | 44.4 | 727,702 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.81 per share. | 28 Aug 2024 | 10,768 | 431,300 | - | 45.8 | 493,282 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.19 per share. | 28 Aug 2024 | 45,640 | 442,068 | - | 45.2 | 2,062,472 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.94 per share. | 28 Aug 2024 | 61,467 | 487,708 | - | 44.9 | 2,762,327 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.23 per share. | 26 Aug 2024 | 77,963 | 642,498 | - | 45.2 | 3,526,266 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.28 per share. | 26 Aug 2024 | 65,403 | 565,561 | - | 44.3 | 2,896,045 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.79 per share. | 26 Aug 2024 | 11,534 | 630,964 | - | 45.8 | 528,142 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.37 per share. | 22 Aug 2024 | 64,133 | 720,461 | - | 46.4 | 2,973,847 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.82 per share. | 22 Aug 2024 | 20,955 | 784,594 | - | 45.8 | 960,158 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.97 per share. | 22 Aug 2024 | 413 | 805,549 | - | 47.0 | 19,399 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.82 per share. | 22 Aug 2024 | 94,908 | 805,962 | - | 45.8 | 4,348,685 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.68 per share. | 20 Aug 2024 | 43,057 | 1,080,416 | - | 45.7 | 1,966,844 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 20 Aug 2024 | 71,245 | 900,870 | - | 47.0 | 3,349,227 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.52 per share. | 20 Aug 2024 | 64,518 | 972,115 | - | 46.5 | 3,001,377 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 47.30 per share. | 20 Aug 2024 | 8,326 | 1,036,633 | - | 47.3 | 393,820 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.94 per share. | 20 Aug 2024 | 35,457 | 1,044,959 | - | 46.9 | 1,664,352 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Aug 2024 | 2,442 | 111,332 | - | 45.0 | 109,914 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 19 Aug 2024 | 310 | 111,022 | - | 46 | 14,260 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 19 Aug 2024 | 296 | 144,875 | - | 46 | 13,616 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Aug 2024 | 2,340 | 145,171 | - | 45.0 | 105,323 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 19 Aug 2024 | 261 | 143,222 | - | 46 | 12,006 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Aug 2024 | 2,060 | 143,483 | - | 45.0 | 92,721 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 16 Aug 2024 | 85,086 | 1,252,577 | - | 45.3 | 3,858,650 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.59 per share. | 16 Aug 2024 | 5,760 | 1,123,473 | - | 46.6 | 268,358 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 16 Aug 2024 | 89,824 | 1,129,233 | - | 46.0 | 4,132,802 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 16 Aug 2024 | 30,448 | 1,219,057 | - | 45.1 | 1,373,205 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 16 Aug 2024 | 3,072 | 1,249,505 | - | 46.2 | 141,896 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.52 per share. | 16 Aug 2024 | 34,485 | 1,337,663 | - | 44.5 | 1,535,272 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.67 per share. | 14 Aug 2024 | 49,601 | 1,372,148 | - | 45.7 | 2,265,278 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 45.25 per share. | 14 Aug 2024 | 131,290 | 1,421,749 | - | 45.3 | 5,940,873 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 43.67 per share. | 14 Aug 2024 | 100,650 | 1,553,039 | - | 43.7 | 4,395,386 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 43.57 per share. | 12 Aug 2024 | 21,428 | 1,653,689 | - | 43.6 | 933,618 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.78 per share. | 12 Aug 2024 | 88,179 | 1,675,117 | - | 42.8 | 3,772,298 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.08 per share. | 12 Aug 2024 | 24,378 | 1,763,296 | - | 42.1 | 1,025,826 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 43.42 per share. | 12 Aug 2024 | 52,076 | 1,787,674 | - | 43.4 | 2,261,140 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 12 Aug 2024 | 26,416 | 1,839,750 | - | 42.7 | 1,129,020 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 40.74 per share. | 08 Aug 2024 | 6,377 | 6,410,416 | - | 40.7 | 259,799 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.04 per share. | 08 Aug 2024 | 1,160 | 6,232,959 | - | 44.0 | 51,086 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 43.44 per share. | 08 Aug 2024 | 40,268 | 6,234,119 | - | 43.4 | 1,749,242 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 08 Aug 2024 | 50,736 | 6,274,387 | - | 42.6 | 2,158,817 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.87 per share. | 08 Aug 2024 | 68,936 | 6,325,123 | - | 42.9 | 2,955,286 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.97 per share. | 08 Aug 2024 | 16,357 | 6,394,059 | - | 43.0 | 702,860 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 40.74 per share. | 08 Aug 2024 | 6,377 | 2,043,623 | - | 40.7 | 259,799 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.97 per share. | 08 Aug 2024 | 16,357 | 2,027,266 | - | 43.0 | 702,860 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 44.04 per share. | 08 Aug 2024 | 1,160 | 1,866,166 | - | 44.0 | 51,086 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 43.44 per share. | 08 Aug 2024 | 40,268 | 1,867,326 | - | 43.4 | 1,749,242 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 08 Aug 2024 | 50,736 | 1,907,594 | - | 42.6 | 2,158,817 | Common Stock |
Dirk Kersten | Director | Sale of securities on an exchange or to another person at price $ 42.87 per share. | 08 Aug 2024 | 68,936 | 1,958,330 | - | 42.9 | 2,955,286 | Common Stock |
Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 10,163 | 60,536 | - | - | Stock option (right to buy) | |
Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 29,787 | 178,579 | - | 5.5 | 165,020 | Common Stock |
Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 29,787 | 70,699 | - | - | Stock option (right to buy) | |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.33 per share. | 21 Jun 2024 | 10,163 | 148,792 | - | 35.3 | 359,059 | Common Stock |
Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 10,163 | 158,955 | - | 5.5 | 56,303 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 21 Jun 2024 | 29,787 | 148,792 | - | 35.0 | 1,042,843 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.34 per share. | 11 Jun 2024 | 2,136 | 147,511 | - | 31.3 | 66,942 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.27 per share. | 11 Jun 2024 | 1,628 | 146,551 | - | 31.3 | 50,908 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.27 per share. | 11 Jun 2024 | 1,008 | 145,543 | - | 31.3 | 31,520 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 31.34 per share. | 10 Jun 2024 | 1,331 | 113,774 | - | 31.3 | 41,714 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 10 Jun 2024 | 1,590 | 115,105 | - | 30.2 | 48,066 | Common Stock |
Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
Dirk Kersten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.51 per share. | 20 May 2024 | 12,147 | 150,792 | - | 33.5 | 407,046 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 20 May 2024 | 17,134 | 162,939 | - | 32.5 | 556,684 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 20 May 2024 | 30,426 | 180,073 | - | 1.0 | 31,339 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 30,426 | 0 | - | - | Stock option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 20 May 2024 | 1,145 | 149,647 | - | 34.1 | 39,022 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 16 May 2024 | 2,126 | 117,157 | - | 28.2 | 59,953 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 16 May 2024 | 462 | 116,695 | - | 28.6 | 13,209 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 16 May 2024 | 483 | 149,647 | - | 28.6 | 13,809 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 16 May 2024 | 2,222 | 150,130 | - | 28.2 | 62,660 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 16 May 2024 | 425 | 148,179 | - | 28.6 | 12,151 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 16 May 2024 | 1,956 | 148,604 | - | 28.2 | 55,159 | Common Stock |
John G. Cox | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 679,853 | 679,853 | - | - | Stock Option (Right to Buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 11 Mar 2024 | 2,081 | 152,352 | - | 25.7 | 53,482 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 11 Mar 2024 | 1,585 | 151,590 | - | 25.7 | 40,735 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.58 per share. | 11 Mar 2024 | 1,030 | 150,560 | - | 25.6 | 26,347 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 08 Mar 2024 | 9,928 | 554,385 | - | 26.1 | 259,121 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 08 Mar 2024 | 40,072 | 564,313 | - | 25.4 | 1,018,630 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 50,000 | 604,385 | - | 5.5 | 277,000 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 08 Mar 2024 | 435 | 554,385 | - | 27.4 | 11,910 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.72 per share. | 08 Mar 2024 | 160,670 | 554,820 | - | 26.7 | 4,293,102 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.30 per share. | 08 Mar 2024 | 202,238 | 715,490 | - | 25.3 | 5,116,621 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 209,412 | 917,728 | - | 5.5 | 1,160,142 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 153,931 | 708,316 | - | 5.5 | 852,778 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 153,931 | 0 | - | - | Stock option (right to buy) | |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.93 per share. | 08 Mar 2024 | 8,618 | 537,998 | - | 25.9 | 223,465 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 26.12 per share. | 08 Mar 2024 | 7,769 | 546,616 | - | 26.1 | 202,926 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 50,000 | 83,269 | - | - | Stock option (right to buy) | |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 209,412 | 133,269 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 08 Mar 2024 | 1,590 | 119,283 | - | 25.0 | 39,734 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 08 Mar 2024 | 1,082 | 120,873 | - | 25.7 | 27,807 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 27.33 per share. | 08 Mar 2024 | 289 | 121,955 | - | 27.3 | 7,898 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 26.72 per share. | 08 Mar 2024 | 55,208 | 122,244 | - | 26.7 | 1,475,158 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 25.31 per share. | 08 Mar 2024 | 30,755 | 177,452 | - | 25.3 | 778,409 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 17,333 | 208,207 | - | 5.5 | 96,025 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 08 Mar 2024 | 68,919 | 190,874 | - | 5.5 | 381,811 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 17,333 | 0 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 68,919 | 9,855 | - | - | Stock option (right to buy) | |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 9,086 | 554,385 | - | 25.8 | 234,873 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 2,273 | 121,955 | - | 25.8 | 58,757 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 2,373 | 154,433 | - | 25.8 | 61,342 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.20 per share. | 07 Mar 2024 | 1,557 | 153,175 | - | 26.2 | 40,793 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.80 per share. | 07 Mar 2024 | 8,364 | 154,732 | - | 25.8 | 215,791 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 29,435 | 1,458,691 | - | 30.1 | 884,522 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 01 Mar 2024 | 17,099 | 847,388 | - | 30.1 | 513,825 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 36,637 | 342,681 | - | - | Stock option (right to buy) | |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 29 Feb 2024 | 5,520 | 568,991 | - | 5.5 | 30,581 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 29 Feb 2024 | 5,520 | 563,471 | - | 27.5 | 151,800 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 29 Feb 2024 | 94,480 | 657,951 | - | 5.5 | 523,419 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 28.25 per share. | 29 Feb 2024 | 18,976 | 638,975 | - | 28.3 | 536,072 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 29.23 per share. | 29 Feb 2024 | 74,090 | 564,885 | - | 29.2 | 2,165,651 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 29.70 per share. | 29 Feb 2024 | 1,414 | 563,471 | - | 29.7 | 41,996 | Common Stock |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,520 | 102,343 | - | - | Stock option (right to buy) | |
Joshua T. Brumm | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 57,843 | 44,500 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 29 Feb 2024 | 3,429 | 124,228 | - | 27.5 | 94,298 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 9,311 | 0 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 3,429 | 9,311 | - | - | Stock option (right to buy) | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 29 Feb 2024 | 564 | 124,228 | - | 28.7 | 16,159 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 28.22 per share. | 29 Feb 2024 | 8,747 | 124,792 | - | 28.2 | 246,840 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 29 Feb 2024 | 9,311 | 133,539 | - | 1.0 | 9,590 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 29 Feb 2024 | 3,429 | 127,657 | - | 1.0 | 3,532 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 28 Feb 2024 | 407 | 163,096 | - | 25 | 10,175 | Common Stock |
P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 360 | 1,488,126 | - | 25.3 | 9,090 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 23,505 | 880,022 | - | 24.4 | 573,052 | Common Stock |
Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 136,312 | 6,216,250 | - | 23.6 | 3,215,600 | Common Stock |
P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 3,821 | 1,511,053 | - | 24.7 | 94,302 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 13,109 | 864,697 | - | 24.8 | 325,496 | Common Stock |
Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 272,923 | 5,878,544 | - | 24.4 | 6,653,863 | Common Stock |
P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 22,567 | 1,488,486 | - | 24.8 | 560,339 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 25,779 | 5,852,765 | - | 24.7 | 636,226 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 9,603 | 1,555,329 | - | 24.0 | 230,280 | Common Stock |
P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 5,580 | 903,527 | - | 24.0 | 133,808 | Common Stock |
P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 210 | 864,487 | - | 25.3 | 5,303 | Common Stock |
P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 11,736 | 909,107 | - | 23.6 | 276,852 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 26 Feb 2024 | 40,455 | 1,514,874 | - | 24.4 | 986,293 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 26 Feb 2024 | 2,216 | 877,806 | - | 24.7 | 54,691 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 26 Feb 2024 | 20,205 | 1,564,932 | - | 23.6 | 476,636 | Common Stock |
P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 25.25 per share. | 26 Feb 2024 | 2,430 | 5,698,091 | - | 25.3 | 61,358 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 26 Feb 2024 | 64,783 | 6,151,467 | - | 24.0 | 1,553,496 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 26 Feb 2024 | 152,244 | 5,700,521 | - | 24.8 | 3,780,219 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 13,738 | 920,843 | - | 22.7 | 311,853 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.44 per share. | 21 Feb 2024 | 149,337 | 6,666,628 | - | 22.4 | 3,351,122 | Common Stock |
Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 21 Feb 2024 | 119,360 | 6,512,104 | - | 22.7 | 2,704,698 | Common Stock |
P. Rhodes Jason | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 21 Feb 2024 | 35,164 | 6,631,464 | - | 23.1 | 813,695 | Common Stock |
P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 23,648 | 1,585,137 | - | 22.7 | 536,810 | Common Stock |
Jason P. Rhodes | Director | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 21 Feb 2024 | 159,542 | 6,352,562 | - | 22.7 | 3,621,603 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 15 Feb 2024 | 166,029 | 6,819,475 | - | 22.7 | 3,770,519 | Common Stock |
Rhodes P. Jason | Director | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 15 Feb 2024 | 175,793 | 7,150,324 | - | 23.9 | 4,197,937 | Common Stock |
P. Jason Rhodes | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 15 Feb 2024 | 162,707 | 6,985,504 | - | 23.1 | 3,765,040 | Common Stock |
Jason Rhodes P. | Director | Sale of securities on an exchange or to another person at price $ 24.45 per share. | 15 Feb 2024 | 2,113 | 7,148,211 | - | 24.5 | 51,663 | Common Stock |
Rhodes Jason P. | Director | Sale of securities on an exchange or to another person at price $ 23.40 per share. | 15 Feb 2024 | 3,510 | 6,815,965 | - | 23.4 | 82,134 | Common Stock |
Farwell Wildon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 12 Feb 2024 | 5,493 | 163,503 | - | 25.1 | 137,710 | Common Stock |
T. Brumm Joshua | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 20,000 | 564,971 | - | 0 | Common Stock | |
T. Brumm Joshua | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jan 2024 | 1,500 | 563,471 | - | 0 | Common Stock | |
Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 24.34 per share. | 26 Jan 2024 | 13,000 | 124,228 | - | 24.3 | 316,420 | Common Stock |
Farwell Wildon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 26 Jan 2024 | 100 | 168,996 | - | 25 | 2,500 | Common Stock |
Richard William Scalzo | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 13,000 | 12,740 | - | - | Stock option (right to buy) | |
Richard Scalzo William | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 26 Jan 2024 | 13,000 | 137,228 | - | 1.0 | 13,390 | Common Stock |
Kersten Dirk | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.50 per share. | 09 Jan 2024 | 1,428,571 | 1,428,571 | - | 17.5 | 24,999,993 | Common Stock |
Kersten Dirk | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.50 per share. | 09 Jan 2024 | 285,714 | 6,416,793 | - | 17.5 | 4,999,995 | Common Stock |
T. Joshua Brumm | CEO & President | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 03 Jan 2024 | 15,382 | 620,772 | - | 18.3 | 282,106 | Common Stock |
Brumm Joshua T. | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 51,183 | 18,536 | - | - | Stock option (right to buy) | |
Richard Scalzo William | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 13,000 | 137,228 | - | 1.0 | 13,390 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 22,674 | 199,259 | - | 1.0 | 23,354 | Common Stock |
T. Brumm Joshua | CEO & President | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 03 Jan 2024 | 16,026 | 584,971 | - | 20.5 | 328,533 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 45,326 | 53,100 | - | - | Stock option (right to buy) | |
Brumm T. Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 51,183 | 636,154 | - | 1.0 | 52,718 | Common Stock |
Brumm T. Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 18,536 | 0 | - | - | Stock option (right to buy) | |
Richard Scalzo William | SVP, Head of Finance & Admin. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 13,000 | 25,740 | - | - | Stock option (right to buy) | |
T. Brumm Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 18,536 | 603,507 | - | 1.0 | 19,092 | Common Stock |
Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 03 Jan 2024 | 15,382 | 206,529 | - | 18.3 | 282,106 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.13 per share. | 03 Jan 2024 | 42,453 | 156,806 | - | 18.1 | 769,673 | Common Stock |
T. Joshua Brumm | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 03 Jan 2024 | 200,000 | 803,507 | - | 5.5 | 1,108,000 | Common Stock |
Beskrovnaya Oxana | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 22,674 | 30,426 | - | - | Stock option (right to buy) | |
Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 03 Jan 2024 | 24,583 | 181,946 | - | 19.0 | 468,306 | Common Stock |
T. Brumm Joshua | CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 200,000 | 107,863 | - | - | Stock option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 03 Jan 2024 | 5,361 | 176,585 | - | 20.5 | 109,901 | Common Stock |
Brumm T. Joshua | CEO & President | Sale of securities on an exchange or to another person at price $ 18.40 per share. | 03 Jan 2024 | 180,235 | 623,272 | - | 18.4 | 3,316,324 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 45,326 | 221,911 | - | 1.0 | 46,686 | Common Stock |
Joshua Brumm T. | CEO & President | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 03 Jan 2024 | 19,775 | 600,997 | - | 19.0 | 376,318 | Common Stock |
Scalzo William Richard | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 18.81 per share. | 03 Jan 2024 | 13,000 | 124,228 | - | 18.8 | 244,530 | Common Stock |
T. Joshua Brumm | CEO & President | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 03 Jan 2024 | 38,301 | 584,971 | - | 19.0 | 729,634 | Common Stock |
William Richard Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 14 Dec 2023 | 2,376 | 124,228 | - | 12.0 | 28,560 | Common Stock |
Scalzo William Richard | See Remarks | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,380 | 126,604 | - | 10.7 | 14,794 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,616 | 187,882 | - | 10.7 | 17,324 | Common Stock |
Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,467 | 176,585 | - | 10.7 | 15,726 | Common Stock |
Farwell Wildon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,688 | 170,074 | - | 10.7 | 18,095 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 7,585 | 584,971 | - | 10.7 | 81,311 | Common Stock |
Farwell Wildon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.55 per share. | 11 Dec 2023 | 978 | 169,096 | - | 10.6 | 10,318 | Common Stock |
McNeill Jonathan | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,245 | 155,518 | - | 10.7 | 13,346 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Dec 2023 | 681 | 129,856 | - | 12.0 | 8,179 | Common Stock |
William Scalzo Richard | See Remarks | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Dec 2023 | 1,872 | 127,984 | - | 12.0 | 22,483 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 358,877 | 592,556 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 139,750 | 139,750 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 94,893 | 189,498 | - | 0 | Common Stock | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 36,952 | 36,952 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 89,742 | 130,537 | - | 0 | Common Stock | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 34,946 | 34,946 | - | - | Stock Option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 93,718 | 178,052 | - | 0 | Common Stock | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 36,495 | 36,495 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 96,158 | 156,763 | - | 0 | Common Stock | |
Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 37,445 | 37,445 | - | - | Stock Option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 82,512 | 171,762 | - | 0 | Common Stock | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 32,131 | 32,131 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 02 Nov 2023 | 9,939 | 94,605 | - | 7.4 | 73,549 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 12,032 | 233,679 | - | 9.4 | 113,221 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 2,672 | 104,544 | - | 9.4 | 25,144 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 1,290 | 40,795 | - | 9.4 | 12,139 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 1,436 | 84,334 | - | 9.4 | 13,513 | Common Stock |
Jonathan McNeill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 1,261 | 60,605 | - | 9.4 | 11,866 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 7,672 | 245,711 | - | 10.4 | 79,866 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,635 | 107,216 | - | 10.4 | 17,020 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,397 | 42,085 | - | 10.4 | 14,543 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,484 | 85,770 | - | 10.4 | 15,448 | Common Stock |
Jonathan McNeill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,266 | 61,866 | - | 10.4 | 13,179 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,707 | 89,250 | - | 10.4 | 17,770 | Common Stock |
Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,390 | 53,482 | - | 12.4 | 17,278 | Common Stock |
Richard William Scalzo | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 40,000 | 38,740 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 13 Jun 2023 | 10,000 | 43,482 | - | 12.0 | 120,300 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 13 Jun 2023 | 40,000 | 53,482 | - | 12.9 | 515,600 | Common Stock |
Richard William Scalzo | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 13 Jun 2023 | 40,000 | 93,482 | - | 1.0 | 41,200 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,625 | 108,851 | - | 12.4 | 20,199 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,475 | 87,254 | - | 12.4 | 18,334 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,698 | 90,957 | - | 12.4 | 21,106 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 12 Jun 2023 | 1,259 | 63,132 | - | 12.4 | 15,649 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 12 Jun 2023 | 1,000 | 64,391 | - | 13 | 13,000 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 302,483 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 1,800 | 300,683 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 30,088 | 330,771 | - | 1.0 | 30,991 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.15 per share. | 08 Jun 2023 | 46,811 | 283,960 | - | 13.2 | 615,565 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.47 per share. | 08 Jun 2023 | 14,189 | 269,771 | - | 13.5 | 191,126 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 76,582 | 346,353 | - | 1.0 | 78,879 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 08 Jun 2023 | 76,582 | 269,771 | - | 13.3 | 1,021,604 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 08 Jun 2023 | 171,360 | 441,131 | - | 1.0 | 176,501 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 08 Jun 2023 | 187,748 | 253,383 | - | 12.6 | 2,367,502 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 30,088 | 317,661 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 76,582 | 241,079 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 171,360 | 69,719 | - | - | Stock Option (right to buy) | |
Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
Dirk Kersten | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 7,318 | 322,483 | - | 13.3 | 97,549 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,559 | 110,476 | - | 13.3 | 20,781 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,311 | 54,872 | - | 13.3 | 17,476 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,416 | 88,729 | - | 13.3 | 18,875 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 7,441 | 92,655 | - | 13.3 | 99,189 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 13 Mar 2023 | 1,000 | 66,600 | - | 13 | 13,000 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 13 Mar 2023 | 1,209 | 65,391 | - | 13.3 | 16,116 | Common Stock |
Jonathan McNeill | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 18 Jan 2023 | 10,000 | 77,600 | - | 0.7 | 7,300 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 18 Jan 2023 | 10,000 | 67,600 | - | 14.0 | 140,300 | Common Stock |
Jonathan McNeill | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 10,000 | 68,528 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 11.57 per share. | 09 Jan 2023 | 30,150 | 67,600 | - | 11.6 | 348,836 | Common Stock |
Jason P. Rhodes | Director | Purchase of securities on an exchange or from another person at price $ 10.70 per share. | 12 Dec 2022 | 934,581 | 934,581 | - | 10.7 | 10,000,017 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 222,000 | 222,000 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 144,000 | 333,123 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 3,322 | 329,801 | - | 10.9 | 36,110 | Common Stock |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 44,000 | 112,786 | - | 0 | Common Stock | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 69,000 | 69,000 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 751 | 112,035 | - | 10.9 | 8,163 | Common Stock |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 312 | 56,183 | - | 10.9 | 3,391 | Common Stock |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 31,000 | 56,495 | - | 0 | Common Stock | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 40,000 | 90,825 | - | 0 | Common Stock | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 680 | 90,145 | - | 10.9 | 7,392 | Common Stock |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 40,000 | 98,222 | - | 0 | Common Stock | |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 472 | 97,750 | - | 10.9 | 5,131 | Common Stock |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 36,000 | 100,724 | - | 0 | Common Stock | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 56,000 | 56,000 | - | - | Stock option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 628 | 100,096 | - | 10.9 | 6,826 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 07 Oct 2022 | 14,200 | 218,823 | - | 1.0 | 14,626 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 195,800 | 347,749 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2022 | 14,200 | 543,549 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Oct 2022 | 2,500 | 189,123 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Oct 2022 | 13,000 | 191,623 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 07 Oct 2022 | 195,800 | 204,623 | - | 12.5 | 2,439,668 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 07 Oct 2022 | 195,800 | 400,423 | - | 1.0 | 201,674 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.37 per share. | 07 Oct 2022 | 14,200 | 204,623 | - | 13.4 | 189,854 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 11,836 | 204,623 | - | 13.7 | 162,153 | Common Stock |
Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 2,629 | 68,786 | - | 13.7 | 36,017 | Common Stock |
Richard William Scalzo | See Remarks | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 840 | 25,495 | - | 13.7 | 11,508 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 1,413 | 50,825 | - | 13.7 | 19,358 | Common Stock |
Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 1,246 | 58,222 | - | 13.7 | 17,070 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 3,480 | 216,459 | - | 14.1 | 48,894 | Common Stock |
Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 786 | 71,415 | - | 14.0 | 11,043 | Common Stock |
Richard William Scalzo | See Remarks | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 326 | 26,335 | - | 14.0 | 4,580 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 712 | 52,238 | - | 14.1 | 10,004 | Common Stock |
Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 494 | 59,468 | - | 14.1 | 6,941 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 658 | 64,724 | - | 14.1 | 9,245 | Common Stock |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 153,931 | 153,931 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 24,118 | 230,902 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 8.24 per share. | 05 Jul 2022 | 10,963 | 219,939 | - | 8.2 | 90,335 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 78,386 | 78,386 | - | - | Stock Option (right to buy) | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 7,222 | 7,222 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 36,219 | 36,219 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 7,222 | 7,222 | - | - | Stock Option (right to buy) | |
Lawrence Otto Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 7,222 | 7,222 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 17,333 | 17,333 | - | - | Stock Option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 23,477 | 23,477 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 21,666 | 21,666 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 3,540 | 206,784 | - | 5.0 | 17,523 | Common Stock |
Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 802 | 72,201 | - | 5.0 | 3,970 | Common Stock |
Richard William Scalzo | See Remarks | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 333 | 26,661 | - | 4.9 | 1,648 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 726 | 52,950 | - | 5.0 | 3,594 | Common Stock |
Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 504 | 59,962 | - | 5.0 | 2,495 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 668 | 65,382 | - | 5.0 | 3,307 | Common Stock |
Edward M. Hurwitz | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Lawrence Otto Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Dirk Kersten | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 3,384 | 210,324 | - | 8.7 | 29,542 | Common Stock |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 765 | 73,003 | - | 8.7 | 6,678 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 308 | 26,994 | - | 8.7 | 2,689 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 693 | 53,676 | - | 8.7 | 6,050 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 481 | 60,466 | - | 8.7 | 4,199 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 640 | 66,050 | - | 8.7 | 5,587 | Common Stock |
Wildon Farwell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.56 per share. | 02 Mar 2022 | 5,617 | 66,690 | - | 8.6 | 48,082 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 118,190 | 213,708 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 177,285 | 177,285 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 40,315 | 73,768 | - | 0 | Common Stock | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 60,472 | 60,472 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 25,044 | 25,044 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 16,696 | 27,302 | - | 0 | Common Stock | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 54,786 | 54,786 | - | - | Stock Option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 36,524 | 54,369 | - | 0 | Common Stock | |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 37,967 | 37,967 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 25,311 | 60,947 | - | 0 | Common Stock | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 67,935 | 67,935 | - | - | Stock Option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 22,307 | 72,307 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2021 | 3,500 | 95,518 | - | 0 | Common Stock | |
Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 23 Sep 2021 | 2,451 | 33,453 | - | 17.2 | 42,206 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 4,584 | 99,018 | - | 16.1 | 73,848 | Common Stock |
Joshua T. Brumm | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 3,425 | 103,602 | - | 15.6 | 53,464 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 367 | 11,098 | - | 15.6 | 5,729 | Common Stock |
Richard William Scalzo | See Remarks | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 492 | 10,606 | - | 16.1 | 7,926 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 827 | 17,845 | - | 16.1 | 13,323 | Common Stock |
Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 617 | 18,672 | - | 15.6 | 9,631 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 545 | 36,365 | - | 15.6 | 8,507 | Common Stock |
Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 729 | 35,636 | - | 16.1 | 11,744 | Common Stock |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
Edward M. Hurwitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Lawrence Otto Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Dirk Kersten | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 19,596 | 19,596 | - | - | Stock Option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
Wildon Farwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 50,000 | 50,000 | - | 0 | Common Stock | |
Jason P. Rhodes | Director | 21 Sep 2020 | 6,029,726 | 8,140,130 | - | - | Common Stock | ||
Jason P. Rhodes | Director | 21 Sep 2020 | 1,608,785 | 1,608,785 | - | - | Common Stock | ||
Jason P. Rhodes | Director | 21 Sep 2020 | 20,000,000 | 0 | - | - | Series A Preferred Stock | ||
Jason P. Rhodes | Director | 21 Sep 2020 | 5,336,179 | 0 | - | - | Series B Preferred Stock | ||
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 107,027 | 107,027 | - | 0 | Common Stock | |
Joshua T. Brumm | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 320,781 | 320,781 | - | - | Stock Option (right to buy) | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 35,904 | 35,904 | - | 0 | Common Stock | |
Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 111,405 | 111,405 | - | - | Stock Option (right to buy) | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 11,465 | 11,465 | - | 0 | Common Stock | |
Richard William Scalzo | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 35,575 | 35,575 | - | - | Stock Option (right to buy) | |
Romesh Subramanian | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 128,185 | 128,185 | - | - | Stock Option (right to buy) | |
Romesh Subramanian | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 41,309 | 566,249 | - | 0 | Common Stock | |
Oxana Beskrovnaya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 19,289 | 19,289 | - | 0 | Common Stock | |
Oxana Beskrovnaya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 59,857 | 59,857 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 52,787 | 52,787 | - | - | Stock Option (right to buy) | |
Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 17,012 | 36,910 | - | 0 | Common Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 260,077 | 743,076 | - | - | Series A Preferred Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 96,576 | 275,932 | - | - | Series A Preferred Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 1,326,313 | 1,326,313 | - | - | Series B Preferred Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 70,492 | 70,492 | - | - | Series B Preferred Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 26,176 | 26,176 | - | - | Series B Preferred Stock | |
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 13,980,992 | 0 | - | - | Series A Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 743,076 | 0 | - | - | Series A Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 275,932 | 0 | - | - | Series A Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 1,326,313 | 0 | - | - | Series B Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 70,492 | 0 | - | - | Series B Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 26,176 | 0 | - | - | Series B Preferred Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 91,081 | 91,081 | - | - | Common Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 245,279 | 245,279 | - | - | Common Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | 31 Jul 2020 | 4,614,943 | 4,614,943 | - | - | Common Stock | ||
Edward M. Hurwitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 4,893,347 | 13,980,992 | - | - | Series A Preferred Stock | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 11,156 | 11,156 | - | - | Stock Option (right to buy) | |
David Charles Lubner | Director | 31 Jul 2020 | 53,625 | 53,625 | - | - | Common Stock | ||
David Charles Lubner | Director | 31 Jul 2020 | 177,872 | 0 | - | - | Series B Preferred Stock | ||
David Charles Lubner | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 177,872 | 177,872 | - | - | Series B Preferred Stock | |
David Charles Lubner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 14,444 | 14,444 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | 31 Jul 2020 | 35,574 | 0 | - | - | Series B Preferred Stock | ||
Catherine Stehman-Breen | Director | 31 Jul 2020 | 10,725 | 115,713 | - | - | Common Stock | ||
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 11,156 | 11,156 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 14,444 | 14,444 | - | - | Stock Option (right to buy) | |
Catherine Stehman-Breen | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 35,574 | 35,574 | - | - | Series B Preferred Stock | |
Lawrence Otto Klein | Director | 31 Jul 2020 | 10,725 | 10,725 | - | - | Common Stock | ||
Lawrence Otto Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 11,156 | 11,156 | - | - | Stock Option (right to buy) | |
Lawrence Otto Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2020 | 14,444 | 14,444 | - | - | Stock Option (right to buy) | |
Lawrence Otto Klein | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jul 2020 | 35,574 | 35,574 | - | - | Series B Preferred Stock | |
Lawrence Otto Klein | Director | 31 Jul 2020 | 35,574 | 0 | - | - | Series B Preferred Stock | ||
Dirk Kersten | Director, Ten Percent Owner | 31 Jul 2020 | 6,131,079 | 6,131,079 | - | - | Common Stock | ||
Dirk Kersten | Director, Ten Percent Owner | 31 Jul 2020 | 5,336,179 | 0 | - | - | Series B Preferred Stock |